Driving Forces Behind the Biosimilar Growth Hormones Market in 2025: Spotlight on Rising Incidence Of Childhood Growth Hormone Deficiency Spurs Global Biosimilar Growth Hormone Market Driver

 What is the current market size and future outlook for the biosimilar growth hormones market?

The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2024 to $0.82 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for growth hormones, patent expirations, clinical evidence, and increasing clinical trials.

The biosimilar growth hormones market size is expected to see strong growth in the next few years. It will grow to $1.19 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to pediatric growth disorders, expanding indications, increase in the diagnosis, and increased awareness of biosimilar options. Major trends in the forecast period include pediatric-focused biosimilars, biosimilar combinations, dosing convenience, biosimilar combinations, and dosing convenience.

Get Your Free Sample of The Global Biosimilar Growth Hormones Market Report:
Biosimilar Growth Hormones Market Trends, Growth, and Share Sample

How has the biosimilar growth hormones market evolved, and what factors have shaped its growth?

The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market. Growth hormone deficiency is caused by damage to the pituitary gland or hypothalamus, which may be the result of an abnormal formation that occurred before the child was born (congenital) or something that occurred during or after birth (acquired). For instance, in September 2023, according to Hormones Australia by the Endocrine Society of Australia (ESA), an Australia-based national authority for the treatment of endocrine related conditions and disease, growth hormone deficiency is estimated to affect 2 to 3 out of every 10,000 people. Therefore, an increase in the number of children suffering from growth deficiencies drives the growth of the biosimilar growth hormones industry.

What are the major segments of the biosimilar growth hormones market?
The biosimilar growth hormones market covered in this report is segmented –

1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

Subsegments:
1) By Intravenous: Hospital-based Administration, Outpatient Clinics
2) By Subcutaneous: Self-administration, Professional Administration
3) By Intramuscular: Pediatric Care, Adult Care
4) By Oral: Tablets, Capsules

Order your report now for swift delivery
Biosimilar Growth Hormones Market Trends, Growth, and Share

Which companies dominate the biosimilar growth hormones market?

Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

Which transformative trends will shape the biosimilar growth hormones market landscape?

Major companies operating in the biosimilar growth hormones market are innovating solutions such as human growth hormone to enhance treatment efficacy and affordability for growth hormone deficiencies. Growth hormone solutions refer to medical treatments or supplements designed to stimulate or replace human growth hormone (HGH) in the body for growth deficiencies or anti-aging purposes. For instance, in June 2023, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based healthcare company, received US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). It is a once-weekly injectable human growth hormone treatment designed for pediatric patients with growth hormone deficiency (GHD). This long-acting growth hormone therapy offers an alternative to daily injections, which can improve adherence and convenience for patients and caregivers. Approval was based on clinical studies demonstrating its efficacy and safety, marking an important advancement in growth hormone therapies.

What are the key regional dynamics of the biosimilar growth hormones market, and which region leads in market share?

North America was the largest region in the biosimilar growth hormone market in 2024. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Does The Biosimilar Growth Hormones Market Report 2025 Offer?

The biosimilar growth hormones market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Biosimilar growth hormone refers to a peptide hormone that promotes cellular regeneration, cell division, and growth in both humans and other animals. Thus, it is crucial to the advancement of humanity. It is a form of mitogen that only affects particular types of cells.

Purchase the exclusive report now to unlock valuable market insights:
Biosimilar Growth Hormones Market Trends, Growth, and Share

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Analyzing the Future of Perimeter Intrusion Detection and Prevention Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities - Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports - By The Business Research Company
Global Market Model: Global Market Intelligence Database